Found: 17
Select item for more details and to access through your institution.
The new era of immune checkpoint inhibition and target therapy in early-stage non-small cell lung cancer. A review of the literature.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 2, p. 108, doi. 10.1016/j.cllc.2021.11.003
- By:
- Publication type:
- Article
Dramatic Antitumor Activity of Nivolumab in Advanced HER2-Positive Lung Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Management of Nonhematologic Toxicities Associated With Different EGFR-TKIs in Advanced NSCLC: A Comparison Analysis.
- Published in:
- Clinical Lung Cancer, 2014, v. 15, n. 4, p. 307, doi. 10.1016/j.cllc.2014.04.006
- By:
- Publication type:
- Article
Co-Occurring Driver Genomic Alterations in Advanced Non-Small-Cell Lung Cancer (NSCLC): A Retrospective Analysis.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 15, p. 4476, doi. 10.3390/jcm13154476
- By:
- Publication type:
- Article
Non-Small-Cell Lung Cancers (NSCLCs) Harboring RET Gene Fusion, from Their Discovery to the Advent of New Selective Potent RET Inhibitors: "Shadows and Fogs".
- Published in:
- Cancers, 2024, v. 16, n. 16, p. 2877, doi. 10.3390/cancers16162877
- By:
- Publication type:
- Article
Post-Progression Analysis of EGFR -Mutant NSCLC Following Osimertinib Therapy in Real-World Settings.
- Published in:
- Cancers, 2024, v. 16, n. 14, p. 2589, doi. 10.3390/cancers16142589
- By:
- Publication type:
- Article
Alectinib vs. Lorlatinib in the Front-Line Setting for ALK-Rearranged Non-Small-Cell Lung Cancer (NSCLC): A Deep Dive into the Main Differences across ALEX and CROWN Phase 3 Trials.
- Published in:
- Cancers, 2024, v. 16, n. 13, p. 2457, doi. 10.3390/cancers16132457
- By:
- Publication type:
- Article
New Generations of Tyrosine Kinase Inhibitors in Treating NSCLC with Oncogene Addiction: Strengths and Limitations.
- Published in:
- Cancers, 2023, v. 15, n. 20, p. 5079, doi. 10.3390/cancers15205079
- By:
- Publication type:
- Article
MET in Non-Small-Cell Lung Cancer (NSCLC): Cross 'a Long and Winding Road' Looking for a Target.
- Published in:
- Cancers, 2023, v. 15, n. 19, p. 4779, doi. 10.3390/cancers15194779
- By:
- Publication type:
- Article
Bone and brain metastasis in lung cancer: recent advances in therapeutic strategies.
- Published in:
- Therapeutic Advances in Medical Oncology, 2014, v. 6, n. 3, p. 101, doi. 10.1177/1758834014521110
- By:
- Publication type:
- Article
Atezolizumab Plus Carboplatin and Etoposide in Patients with Untreated Extensive-Stage Small-Cell Lung Cancer: Interim Results of the MAURIS Phase IIIb Trial.
- Published in:
- Oncologist, 2024, v. 29, n. 5, p. e690, doi. 10.1093/oncolo/oyad342
- By:
- Publication type:
- Article
Comparison of real-world data (RWD) analysis on efficacy and post-progression outcomes with pembrolizumab plus chemo vs chemo alone in metastatic non-squamous non-small cell lung cancer with PD-L1 < 50%.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.980765
- By:
- Publication type:
- Article
The Evolving Scenario of ES-SCLC Management: From Biology to New Cancer Therapeutics.
- Published in:
- Genes, 2024, v. 15, n. 6, p. 701, doi. 10.3390/genes15060701
- By:
- Publication type:
- Article
Fears and Perception of the Impact of COVID-19 on Patients With Lung Cancer: A Mono-Institutional Survey.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.584612
- By:
- Publication type:
- Article
Results of Multilevel Containment Measures to Better Protect Lung Cancer Patients From COVID-19: The IEO Model.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. 1, doi. 10.3389/fonc.2020.00665
- By:
- Publication type:
- Article
Management of Non-Metastatic Non-Small Cell Lung Cancer (NSCLC) with Driver Gene Alterations: An Evolving Scenario.
- Published in:
- Current Oncology, 2024, v. 31, n. 9, p. 5121, doi. 10.3390/curroncol31090379
- By:
- Publication type:
- Article
Sustained Improvement in the Management of Patients with Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocation: Where Are We Running?
- Published in:
- Current Oncology, 2023, v. 30, n. 5, p. 5072, doi. 10.3390/curroncol30050384
- By:
- Publication type:
- Article